Randomized, placebo-controlled, double-blind study of a cytomegalovirus-specific monoclonal antibody (MSL-109) for prevention of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation (Q43682605)

From Wikidata

Jump to navigation Jump to search

scientific article published in January 2001

Language	Label	Description	Also known as
English	Randomized, placebo-controlled, double-blind study of a cytomegalovirus-specific monoclonal antibody (MSL-109) for prevention of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation	scientific article published in January 2001

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Randomized, placebo-controlled, double-blind study of a cytomegalovirus-specific monoclonal antibody (MSL-109) for prevention of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Cytomegalovirus

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

cytomegaloviral disease

1 reference

based on heuristic

inferred from title

author name string

M Boeckh

1

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

R A Bowden

2

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

B Storer

3

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

N J Chao

4

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

R Spielberger

5

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

D K Tierney

6

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

G Gallez-Hawkins

7

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

T Cunningham

8

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

K G Blume

9

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

D Levitt

10

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

J A Zaia

11

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

publication date

1 January 2001

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Biology of Blood and Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

343-351

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2801%2980005-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Early treatment with ganciclovir to prevent cytomegalovirus disease after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2801%2980005-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevention of cytomegalovirus infection by cytomegalovirus immune globulin after marrow transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2801%2980005-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Cytomegalovirus (CMV)-Specific Intravenous Immunoglobulin for the Prevention of Primary CMV Infection and Disease after Marrow Transplant

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2801%2980005-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Human cytomegalovirus glycoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2801%2980005-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Human monoclonal anti-cytomegalovirus (CMV) antibody (MSL 109): enhancement of in vitro foscarnet- and ganciclovir-induced inhibition of CMV replication

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2801%2980005-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I study of safety and pharmacokinetics of a human anticytomegalovirus monoclonal antibody in allogeneic bone marrow transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2801%2980005-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Human Monoclonal Antibodies Neutralizing Cytomegalovirus (CMV) for Prophylaxis of CMV Disease: Report of a Phase I Trial in Bone Marrow Transplant Recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2801%2980005-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Cytomegalovirus pneumonia after bone marrow transplantation successfully treated with the combination of ganciclovir and high-dose intravenous immune globulin

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2801%2980005-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of cytomegalovirus pneumonia with ganciclovir and intravenous cytomegalovirus immunoglobulin in patients with bone marrow transplants

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2801%2980005-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Cytomegalovirus immune globulin prophylaxis in liver transplantation. A randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2801%2980005-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Results of different strategies for reducing cytomegalovirus-associated mortality in allogeneic stem cell transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2801%2980005-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of CMV Brite kit for detection of cytomegalovirus pp65 antigenemia in peripheral blood leukocytes by immunofluorescence.

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2801%2980005-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of a quantitative plasma PCR plate assay for detecting cytomegalovirus infection in marrow transplant recipients.

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2801%2980005-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2801%2980005-7

7 January 2021

based on heuristic

inferred from DOI database lookup

The humoral immune response against human cytomegalovirus is characterized by a delayed synthesis of glycoprotein-specific antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2801%2980005-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Kinetics of the antibody response against human cytomegalovirus-specific proteins in allogeneic bone marrow transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2801%2980005-7

7 January 2021

based on heuristic

inferred from DOI database lookup

The protective effects of hyperimmune anti-murine cytomegalovirus antiserum against lethal viral challenge: the case for passive-active immunization

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2801%2980005-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Valacyclovir for the prevention of cytomegalovirus disease after renal transplantation. International Valacyclovir Cytomegalovirus Prophylaxis Transplantation Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2801%2980005-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Impact of prophylactic immediate posttransplant ganciclovir on development of transplant atherosclerosis: a post hoc analysis of a randomized, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2801%2980005-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1083-8791(01)80005-7

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43682605&oldid=2102452656"